Skip to main content
SpringerLink
Log in

Clinical characteristics of lupus myocarditis in Korea

  • Case Report
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Clinically important myocarditis is an unusual feature in systemic lupus erythematosus (SLE). We describe the clinical characteristics, management and outcomes of five SLE patients who developed severe left ventricular dysfunction. Four patients were female with mean age of 36.4 years. Three patients had both lupus myocarditis and lupus nephritis. Four patients had raised anti-dsDNA antibody titer and low complement level and two patients had positive IgG anticardiolipin antibody. Three patients were treated by high-dose corticosteroids, one patient by intravenous pulse methylprednisolone, and one patient by intravenous immunoglobulin and pulse cyclophosphamide with high dose corticosteroids. Left ventricular function improved markedly in four patients and all of them had no recurrence of lupus myocarditis up to follow-up of 33 months. However, one patient, who showed no improvement of left ventricular function, was expired due to sudden cardiac arrest. Lupus myocarditis should be treated by immunosuppressive therapy with high-dose corticosteroids and mostly the prognosis might be good with early treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. D’Cruz D, Khamashta M, Huges GRV (2001) Cardiovascular manifestation of systemic lupus erythematosus. In: Wallace DJ, Hahn BH (eds) Dubois’ lupus erythematous. Lippincott Williams and Wilkins, Philadelphia pp 645

    Google Scholar 

  2. Kao AH, Manzi S (2002) How to manage patients with cardiopulmonary disease? Best Pract Res Clin Rheumatol 16:211–227

    Article  PubMed  Google Scholar 

  3. Wijetunga M, Rockson S (2002) Myocarditis in systemic lupus erythematosus. Am J Med 113:419–423

    Article  PubMed  Google Scholar 

  4. Moder KG, Miller TD, Tazelaar HD (1999) Cardiac involvement in systemic lupus erythematosus. Mayo Clin Proc 74:275–284

    Article  PubMed  CAS  Google Scholar 

  5. Sasson Z, Rasooly Y, Chow CW, Marshall S, Urowitz MB (1992) Impairment of left ventricular diastolic function in systemic lupus erythematosus. Am J Cardiol 69:1629–1634

    Article  PubMed  CAS  Google Scholar 

  6. Cervera R, Font J, Pare C et al (1992) Cardiac disease in systemic lupus erythematosus: prospective study of 70 patients. Ann Rheum Dis 51:156–159

    PubMed  CAS  Google Scholar 

  7. Doherty NE, Siegel RJ (1985) Cardiovascular manifestations of systemic lupus erythematosus. Am Heart J 110:1257–1265

    Article  PubMed  CAS  Google Scholar 

  8. Feldman AM, McNamara D (2000) Myocarditis. N Eng J Med 343:1388–1398

    Article  CAS  Google Scholar 

  9. Murphy JG, Franz RP (2003) Endomyocardial biopsy in myocarditis. In: Cooper LT (Ed) Myocarditis: from bench to bedside. Humana, Totowa

    Google Scholar 

  10. Noutsias M, Pauschinger M, Poller WC, Schultheiss HP, Kuhl U (2003) Current insights into the pathogenesis, diagnosis and therapy of inflammatory cardiomyopathy. Heart Fail Monit 3:127–135

    PubMed  Google Scholar 

  11. Biadani AK, Roberts JL, Schwartz MM, Lewis EJ (1980) Immunopathology of cardiac lesions in fatal systemic lupus erythematosus. Am J Med 69:849–858

    Article  Google Scholar 

  12. Logar D, Kveder T, Rozman B, Dovovisek J (1990) Possible association between anti-Ro antibodies and myocarditis or cardiac conduction defects in adults with systemic lupus erythematosus. Ann Rheum Dis 49:627–629

    Article  PubMed  CAS  Google Scholar 

  13. Leung WH, Wong KL, Lau CP, Wong CK, Liu HW (1990) Association between antiphospholipid antibodies and cardiac abnormalities in patients with systemic lupus erythematosus. Am J Med 89:411–419

    Article  PubMed  CAS  Google Scholar 

  14. Comin-Colet J, Saches-Corral MA, Alegre-Sancho JJ, Valverde J, Lopez-Gomez D, Sabate X et al (2001) Complete heart block in an adult with systemic lupus erythematosus and recent onset of hydroxychloroquine therapy. Lupus 10:59–62

    Article  PubMed  CAS  Google Scholar 

  15. Law WG, Thong BY, Lian TY, Kong KO, Chng HH (2005) Acute lupus myocarditis: clinical features and outcome of an oriental series. Lupus 14:827–831

    Article  PubMed  CAS  Google Scholar 

  16. Mason JW, O’Connel JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, Moon TE (1995) For the myocarditis treatment trial investigators. A clinical trial of immunosuppressive therapy for myocarditis. N Eng J Med 333:269–275

    Article  CAS  Google Scholar 

  17. McNamara DM, Holubkov R, Starling RC, Dec GW, Loh E, Torre-Amione G, Gass A, Janosko K, Tokarcznk T, Kessler P, Mann DL, Feldman AM (2001) Controlled trial of intravenous immunoglobulin in recent-onset dialted cardiomyopathy. Circulation 103:2254–2259

    PubMed  CAS  Google Scholar 

  18. Frustaci A, Gentiloni N, Caldarulo M (1996) Acute myocarditis and left ventricular aneurysm as presentations of systemic lupus erythematosus. Chest 109:282–284

    PubMed  CAS  Google Scholar 

  19. Chan YK, Li EK, Tam LS, Chow LT, Ng HK (2003) Intravenous cyclophosphamide improves cardiac dysfunction in lupus myocarditis. Scand J Rheumatol 32:306–308

    Article  PubMed  CAS  Google Scholar 

  20. Naarendorp M, Kerr LD, Khan AS, Ornstein MH (1999) Dramatic improvement of left ventricular function after cytotoxic therapy in lupus patients with acute cardiomyopathy: report of six cases. J Rheumatol 26:2257–2260

    PubMed  CAS  Google Scholar 

  21. Sherer Y, Levy Y, Shoenfeld Y (1999) Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus. Clin Rheumatol 18:238–240

    Article  PubMed  CAS  Google Scholar 

  22. Jacques E, Sophie R, Patrick A, Didier C, Xavier M (2004) Specific cardiomyopathy in lupus patients: report of three cases. Joint Bone Spine 71:66–69

    Article  Google Scholar 

  23. Doria A, Iaccarino L, Sarzi-Puttini P, Atzeni F, Turriel M, Petri MA (2005) Cardiac involvement in systemic lupus erythematosus. Lupus 14:683–686

    Article  PubMed  CAS  Google Scholar 

  24. Lazzerini PE, Acampa M, Guideri F, Capecchi PL, Campanella V, Morozzi G et al (2004) Prolongation of the corrected QT intervals in adult patients with anti-Ro/SSA positive connective tissue diseases. Arthritis Rheum 50:1248–1252

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Allergy and Rheumatology, Ajou University School of Medicine, Woncheon-dong, San5, Youngtong-gu, Suwon, 443-721, South Korea

    Jae-Wook Chung, Dai-Yeol Joe, Han-Jung Park, Hyoun-Ah Kim, Hae-Sim Park & Chang-Hee Suh

Authors
  1. Jae-Wook Chung
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dai-Yeol Joe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Han-Jung Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hyoun-Ah Kim
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hae-Sim Park
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Chang-Hee Suh
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Chang-Hee Suh.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chung, JW., Joe, DY., Park, HJ. et al. Clinical characteristics of lupus myocarditis in Korea. Rheumatol Int 28, 275–280 (2008). https://doi.org/10.1007/s00296-007-0414-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-007-0414-6

Keywords

Search

Navigation